{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:32:13Z","timestamp":1762507933557,"version":"3.37.3"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T00:00:00Z","timestamp":1574294400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T00:00:00Z","timestamp":1574294400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s12032-019-1332-7","type":"journal-article","created":{"date-parts":[[2019,12,16]],"date-time":"2019-12-16T16:29:59Z","timestamp":1576513799000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Prognostic impact of C-reactive protein-albumin ratio for the lethality in castration-resistant prostate cancer"],"prefix":"10.1007","volume":"37","author":[{"given":"Taizo","family":"Uchimoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4157-1929","authenticated-orcid":false,"given":"Kazumasa","family":"Komura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuya","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenkichi","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Tanda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohisa","family":"Matsunaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Ichihashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Tsutsumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Tsujino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yudai","family":"Nishimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoaki","family":"Takai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichiro","family":"Minami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohei","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohito","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirofumi","family":"Uehara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajime","family":"Hirano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hayahito","family":"Nomi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naokazu","family":"Ibuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoshi","family":"Takahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teruo","family":"Inamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruhito","family":"Azuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,11,21]]},"reference":[{"issue":"1","key":"1332_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21551","volume":"69","author":"RL Siegel","year":"2019","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7\u201334.","journal-title":"CA Cancer J Clin"},{"issue":"14","key":"1332_CR2","doi-asserted-by":"publisher","first-page":"4480","DOI":"10.1158\/1078-0432.CCR-18-4046","volume":"25","author":"YZ Mazzu","year":"2019","unstructured":"Mazzu YZ, Armenia J, Chakraborty G, et al. A novel mechanism driving poor-prognosis prostate cancer: overexpression of the DNA repair gene, ribonucleotide reductase small subunit M2 (RRM2). Clin Cancer Res. 2019;25(14):4480\u201392.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"1332_CR3","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41389-018-0039-5","volume":"7","author":"T Sun","year":"2018","unstructured":"Sun T, Du SY, Armenia J, et al. Expression of lncRNA MIR222HG co-transcribed from the miR-221\/222 gene promoter facilitates the development of castration-resistant prostate cancer. Oncogenesis. 2018;7(3):30.","journal-title":"Oncogenesis"},{"issue":"7","key":"1332_CR4","doi-asserted-by":"publisher","first-page":"2979","DOI":"10.1172\/JCI96769","volume":"128","author":"K Komura","year":"2018","unstructured":"Komura K, Yoshikawa Y, Shimamura T, et al. ATR inhibition controls aggressive prostate tumors deficient in Y-linked histone demethylase KDM5D. J Clin Investig. 2018;128(7):2979\u201395.","journal-title":"J Clin Investig"},{"issue":"22","key":"1332_CR5","doi-asserted-by":"publisher","first-page":"6259","DOI":"10.1073\/pnas.1600420113","volume":"113","author":"K Komura","year":"2016","unstructured":"Komura K, Jeong SH, Hinohara K, et al. Resistance to docetaxel in prostate cancer is associated with androgen receptor activation and loss of KDM5D expression. Proc Natl Acad Sci USA. 2016;113(22):6259\u201364.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"1332_CR6","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/iju.13512","volume":"25","author":"K Komura","year":"2018","unstructured":"Komura K, Sweeney CJ, Inamoto T, Ibuki N, Azuma H, Kantoff PW. Current treatment strategies for advanced prostate cancer. Int J Urol. 2018;25(3):220\u201331.","journal-title":"Int J Urol"},{"issue":"11","key":"1332_CR7","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1002\/ijc.31256","volume":"142","author":"R Arthur","year":"2018","unstructured":"Arthur R, Williams R, Garmo H, et al. Serum inflammatory markers in relation to prostate cancer severity and death in the Swedish AMORIS study. Int J Cancer. 2018;142(11):2254\u201362.","journal-title":"Int J Cancer"},{"issue":"1","key":"1332_CR8","doi-asserted-by":"publisher","first-page":"8143","DOI":"10.1038\/s41598-019-44653-x","volume":"9","author":"JR Yang","year":"2019","unstructured":"Yang JR, Xu JY, Chen GC, et al. Post-diagnostic C-reactive protein and albumin predict survival in Chinese patients with non-small cell lung cancer: a prospective cohort study. Sci Rep. 2019;9(1):8143.","journal-title":"Sci Rep"},{"issue":"6","key":"1332_CR9","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1111\/ajco.13055","volume":"14","author":"XF Ni","year":"2018","unstructured":"Ni XF, Wu J, Ji M, et al. Effect of C-reactive protein\/albumin ratio on prognosis in advanced non-small-cell lung cancer. Asia Pac J Clin Oncol. 2018;14(6):402\u20139.","journal-title":"Asia Pac J Clin Oncol"},{"issue":"5","key":"1332_CR10","doi-asserted-by":"crossref","first-page":"8835","DOI":"10.18632\/oncotarget.13053","volume":"8","author":"F Zhang","year":"2017","unstructured":"Zhang F, Ying L, Jin J, et al. The C-reactive protein\/albumin ratio predicts long-term outcomes of patients with operable non-small cell lung cancer. Oncotarget. 2017;8(5):8835\u201342.","journal-title":"Oncotarget"},{"issue":"7","key":"1332_CR11","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1007\/s00595-016-1448-8","volume":"47","author":"T Miyazaki","year":"2017","unstructured":"Miyazaki T, Yamasaki N, Tsuchiya T, et al. Ratio of C-reactive protein to albumin is a prognostic factor for operable non-small-cell lung cancer in elderly patients. Surg Today. 2017;47(7):836\u201343.","journal-title":"Surg Today"},{"issue":"19","key":"1332_CR12","doi-asserted-by":"publisher","first-page":"e6848","DOI":"10.1097\/MD.0000000000006848","volume":"96","author":"YW Koh","year":"2017","unstructured":"Koh YW, Lee HW. Prognostic impact of C-reactive protein\/albumin ratio on the overall survival of patients with advanced nonsmall cell lung cancers receiving palliative chemotherapy. Medicine (Baltimore). 2017;96(19):e6848.","journal-title":"Medicine (Baltimore)."},{"issue":"10","key":"1332_CR13","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1111\/iju.14078","volume":"26","author":"S Konishi","year":"2019","unstructured":"Konishi S, Hatakeyama S, Tanaka T, et al. C-reactive protein\/albumin ratio is a predictive factor for prognosis in patients with metastatic renal cell carcinoma. Int J Urol. 2019;26(10):992\u20138.","journal-title":"Int J Urol"},{"issue":"10","key":"1332_CR14","first-page":"e0224266","volume":"14","author":"T Tsujino","year":"2019","unstructured":"Tsujino T, Komura K, Hashimoto T, et al. C-reactive protein-albumin ratio as a prognostic factor in renal cell carcinoma\u2014a data from multi-institutional study in Japan. Urol Oncol. 2019;14(10):e0224266.","journal-title":"Urol Oncol"},{"issue":"13","key":"1332_CR15","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.2217\/fon-2018-0611","volume":"15","author":"J Gao","year":"2019","unstructured":"Gao J, Agizamhan S, Zhao X, et al. Preoperative C-reactive protein\/albumin ratio predicts outcome of surgical papillary renal cell carcinoma. Future Oncol. 2019;15(13):1459\u201368.","journal-title":"Future Oncol"},{"issue":"1","key":"1332_CR16","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s12885-017-3119-6","volume":"17","author":"S Guo","year":"2017","unstructured":"Guo S, He X, Chen Q, et al. The C-reactive protein\/albumin ratio, a validated prognostic score, predicts outcome of surgical renal cell carcinoma patients. BMC Cancer. 2017;17(1):171.","journal-title":"BMC Cancer"},{"issue":"11","key":"1332_CR17","first-page":"14893","volume":"8","author":"Z Chen","year":"2015","unstructured":"Chen Z, Shao Y, Fan M, et al. Prognostic significance of preoperative C-reactive protein: albumin ratio in patients with clear cell renal cell carcinoma. Int J Clin Exp Pathol. 2015;8(11):14893\u2013900.","journal-title":"Int J Clin Exp Pathol"},{"key":"1332_CR18","doi-asserted-by":"publisher","first-page":"4789","DOI":"10.2147\/CMAR.S180301","volume":"10","author":"Y Guo","year":"2018","unstructured":"Guo Y, Cai K, Mao S, et al. Preoperative C-reactive protein\/albumin ratio is a significant predictor of survival in bladder cancer patients after radical cystectomy: a retrospective study. Cancer Manag Res. 2018;10:4789\u2013804.","journal-title":"Cancer Manag Res"},{"issue":"2","key":"1332_CR19","first-page":"370","volume":"8","author":"M Kunizaki","year":"2018","unstructured":"Kunizaki M, Tominaga T, Wakata K, et al. Clinical significance of the C-reactive protein-to-albumin ratio for the prognosis of patients with esophageal squamous cell carcinoma. Mol Clin Oncol. 2018;8(2):370\u20134.","journal-title":"Mol Clin Oncol"},{"issue":"5","key":"1332_CR20","doi-asserted-by":"publisher","first-page":"807","DOI":"10.7150\/jca.22755","volume":"9","author":"X Yu","year":"2018","unstructured":"Yu X, Wen Y, Lin Y, et al. The value of preoperative glasgow prognostic score and the C-reactive protein to albumin ratio as prognostic factors for long-term survival in pathological T1N0 esophageal squamous cell carcinoma. J Cancer. 2018;9(5):807\u201315.","journal-title":"J Cancer"},{"issue":"1","key":"1332_CR21","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1186\/s12885-019-5747-5","volume":"19","author":"MT Wu","year":"2019","unstructured":"Wu MT, He SY, Chen SL, et al. Clinical and prognostic implications of pretreatment albumin to C-reactive protein ratio in patients with hepatocellular carcinoma. BMC Cancer. 2019;19(1):538.","journal-title":"BMC Cancer"},{"issue":"7","key":"1332_CR22","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1007\/s00268-017-4446-0","volume":"42","author":"T Shimizu","year":"2018","unstructured":"Shimizu T, Ishizuka M, Suzuki T, et al. The value of the C-reactive protein-to-albumin ratio is useful for predicting survival of patients with child-pugh class a undergoing liver resection for hepatocellular carcinoma. World J Surg. 2018;42(7):2218\u201326.","journal-title":"World J Surg"},{"issue":"3","key":"1332_CR23","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1245\/s10434-014-4048-0","volume":"22","author":"A Kinoshita","year":"2015","unstructured":"Kinoshita A, Onoda H, Imai N, et al. The C-reactive protein\/albumin ratio, a novel inflammation-based prognostic score, predicts outcomes in patients with hepatocellular carcinoma. Ann Surg Oncol. 2015;22(3):803\u201310.","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"1332_CR24","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1002\/hed.25565","volume":"41","author":"A Kuboki","year":"2019","unstructured":"Kuboki A, Kanaya H, Nakayama T, et al. Prognostic value of C-reactive protein\/albumin ratio for patients with hypopharyngeal and laryngeal cancer undergoing invasive surgery involving laryngectomy. Head Neck. 2019;41(5):1342\u201350.","journal-title":"Head Neck"},{"issue":"20","key":"1332_CR25","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","volume":"310","author":"World Medical A","year":"2013","unstructured":"World Medical A. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191\u20134.","journal-title":"JAMA"},{"issue":"7","key":"1332_CR26","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1200\/JCO.2007.12.4487","volume":"26","author":"HI Scher","year":"2008","unstructured":"Scher HI, Halabi S, Tannock I, et al. Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group. J Clin Oncol. 2008;26(7):1148\u201359.","journal-title":"J Clin Oncol"},{"issue":"1","key":"1332_CR27","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3","volume":"3","author":"WJ Youden","year":"1950","unstructured":"Youden WJ. Index for rating diagnostic tests. Cancer. 1950;3(1):32\u20135.","journal-title":"Cancer"},{"key":"1332_CR28","doi-asserted-by":"publisher","first-page":"3762651","DOI":"10.1155\/2017\/3762651","volume":"2017","author":"I Unal","year":"2017","unstructured":"Unal I. Defining an optimal cut-point value in ROC analysis: an alternative approach. Comput Math Methods Med. 2017;2017:3762651.","journal-title":"Comput Math Methods Med"},{"issue":"4","key":"1332_CR29","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4","volume":"15","author":"FE Harrell Jr","year":"1996","unstructured":"Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15(4):361\u201387.","journal-title":"Stat Med"},{"issue":"9","key":"1332_CR30","doi-asserted-by":"publisher","first-page":"2994","DOI":"10.1245\/s10434-019-07530-5","volume":"26","author":"K Komura","year":"2019","unstructured":"Komura K, Hashimoto T, Tsujino T, et al. The CANLPH score, an integrative model of systemic inflammation and nutrition status (SINS), predicts clinical outcomes after surgery in renal cell carcinoma: data from a multicenter cohort in Japan. Ann Surg Oncol. 2019;26(9):2994\u20133004.","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"1332_CR31","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1007\/s00345-018-2590-2","volume":"37","author":"T Okamoto","year":"2019","unstructured":"Okamoto T, Hatakeyama S, Narita S, et al. Impact of nutritional status on the prognosis of patients with metastatic hormone-naive prostate cancer: a multicenter retrospective cohort study in Japan. World J Urol. 2019;37(9):1827\u201335.","journal-title":"World J Urol"},{"issue":"3","key":"1332_CR32","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1002\/cncr.22029","volume":"107","author":"TM Beer","year":"2006","unstructured":"Beer TM, Tangen CM, Bland LB, et al. The prognostic value of hemoglobin change after initiating androgen-deprivation therapy for newly diagnosed metastatic prostate cancer: a multivariate analysis of Southwest Oncology Group Study 8894. Cancer. 2006;107(3):489\u201396.","journal-title":"Cancer"},{"key":"1332_CR33","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1186\/1471-2407-13-292","volume":"13","author":"K Shafique","year":"2013","unstructured":"Shafique K, Proctor MJ, McMillan DC, et al. The modified Glasgow prognostic score in prostate cancer: results from a retrospective clinical series of 744 patients. BMC Cancer. 2013;13:292.","journal-title":"BMC Cancer"},{"issue":"3","key":"1332_CR34","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1093\/annonc\/mdt581","volume":"25","author":"R Leibowitz-Amit","year":"2014","unstructured":"Leibowitz-Amit R, Templeton AJ, Omlin A, et al. Clinical variables associated with PSA response to abiraterone acetate in patients with metastatic castration-resistant prostate cancer. Ann Oncol. 2014;25(3):657\u201362.","journal-title":"Ann Oncol"},{"issue":"3","key":"1332_CR35","doi-asserted-by":"publisher","first-page":"467","DOI":"10.4103\/1008-682X.123686","volume":"16","author":"ZQ Liu","year":"2014","unstructured":"Liu ZQ, Chu L, Fang JM, et al. Prognostic role of C-reactive protein in prostate cancer: a systematic review and meta-analysis. Asian J Androl. 2014;16(3):467\u201371.","journal-title":"Asian J Androl"},{"issue":"3","key":"1332_CR36","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/sj.pcan.4500418","volume":"3","author":"E Richter","year":"2000","unstructured":"Richter E, Connelly RR, Moul JW. The role of pretreatment serum albumin to predict pathological stage and recurrence among radical prostatectomy cases. Prostate Cancer Prostatic Dis. 2000;3(3):186\u201390.","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"10","key":"1332_CR37","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1002\/pros.23373","volume":"77","author":"K Mori","year":"2017","unstructured":"Mori K, Kimura T, Onuma H, et al. Lactate dehydrogenase predicts combined progression-free survival after sequential therapy with abiraterone and enzalutamide for patients with castration-resistant prostate cancer. Prostate. 2017;77(10):1144\u201350.","journal-title":"Prostate"},{"issue":"2","key":"1332_CR38","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.eururo.2014.09.022","volume":"68","author":"G Gravis","year":"2015","unstructured":"Gravis G, Boher JM, Fizazi K, et al. Prognostic factors for survival in noncastrate metastatic prostate cancer: validation of the glass model and development of a novel simplified prognostic model. Eur Urol. 2015;68(2):196\u2013204.","journal-title":"Eur Urol"},{"issue":"3","key":"1332_CR39","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1158\/1078-0432.CCR-16-1070","volume":"23","author":"F Qu","year":"2017","unstructured":"Qu F, Xie W, Nakabayashi M, et al. Association of AR-V7 and prostate-specific antigen RNA levels in blood with efficacy of abiraterone acetate and enzalutamide treatment in men with prostate cancer. Clin Cancer Res. 2017;23(3):726\u201334.","journal-title":"Clin Cancer Res"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-019-1332-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12032-019-1332-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-019-1332-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T03:34:58Z","timestamp":1605843298000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12032-019-1332-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,21]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["1332"],"URL":"https:\/\/doi.org\/10.1007\/s12032-019-1332-7","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"type":"print","value":"1357-0560"},{"type":"electronic","value":"1559-131X"}],"subject":[],"published":{"date-parts":[[2019,11,21]]},"assertion":[{"value":"10 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors declared that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study design was approved in the institutional review board of Osaka Medical College (IRB Approval Number: RIN-750-2571).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"9"}}